Sfoglia per Autore
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703)
2001-01-01 DE VITA, Salvatore; De Marchi, G; Sacco, S; Gremese, E; Fabris, M; Ferraccioli, G. F.
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results
2002-01-01 Fabris, Martina; Di Poi, E.; Sacco, S.; Damante, Giuseppe; Sinigaglia, L.; Ferraccioli, Gianfranco
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis.
2002-01-01 Damante, Giuseppe; D'Elia, Angela Valentina; Di, Pe; Fabris, Martina; Ferraccioli, Gianfranco; Sinigaglia, L.
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis
2004-01-01 Quartuccio, Luca; Fabris, M; Ferraccioli, G.
SYSTEMIC CONNECTIVE TISSUE DISEASE COMPLICATED BY CASTLEMAN'S DISEASE: REPORT OF A CASE AND REVIEW OF THE LITERATURE
2004-01-01 DE MARCHI, G; DE VITA, Salvatore; Fabris, M; Scott, Cathryn Anne; Ferraccioli, G.
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS
2005-01-01 Tolusso, B; Fabris, M; Caporali, R; Cuomo, G; Isola, Miriam; Soldano, F; Montecucco, C; Valentini, G; Ferraccioli, G.
Type II mixed cryglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses
2006-01-01 Boiocchi, M; Carbone, A; Damacco, F; DE RE, V; DE VITA, Salvatore; Fabris, Martina; Gasparotto, D; Gloghini, A; Marzotto, A; Sansonno, D; Simula, M. P.; Tucci, F. A.
Rituximab treatment for Glomerulonephritis in HCV-associated Mixed Cryoglobulinemia: efficacy and safety in the lack of steroids
2006-01-01 Quartuccio, Luca; Soardo, G; Romano, Giulio; Zaja, F; Scott, Cathryn Anne; DE MARCHI, G; Fabris, M; Ferraccioli, G; DE VITA, Salvatore
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations
2006-01-01 De Re, V.; Sansonno, D.; Simula, M. P.; Caggiari, L.; Gasparotto, D; Fabris, M.; Tucci, F. A.; Racanelli, V.; Talamini, R; Campagnolo, M.; Geremia, S.; Dammacco, F.; De Vita, S.
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
2006-01-01 Quartuccio, Luca; De Re, V.; Fabris, M; Marzotto, A.; Franzolini, N; Gasparotto, D.; Caggiari, L.; Ferraccioli, G.; Scott, Cathryn Anne; DE VITA, Salvatore
Twist is substrate for caspase cleavage and proteasome-mediated degradation
2006-01-01 Demontis, S; Rigo, C; Piccinin, S; Mizzau, Michela; Sonego, Maura; Fabris, Martina; Brancolini, Claudio; Maestro, R.
Rituximab in mixed cryoglobulinemia: increased experience and perspectives
2007-01-01 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: Association with nephritis RID A-8026-2008
2007-01-01 Quartuccio, Luca; Fabris, M; Salvin, S; Isola, Miriam; Soldano, F; Falleti, E; Beltrami, Ca; De Re, V; DE VITA, Salvatore
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication.
2007-01-01 Quartuccio, Luca; De Marchi, G.; Fabris, M.; DE VITA, Salvatore
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease
2007-01-01 Fabris, M; Visentini, D; De Re, V; Picierno, A; Maieron, R; Cannizzaro, R; Villalta, D; Curcio, Francesco; DE VITA, Salvatore; Tonutti, E.
B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection
2007-01-01 Fabris, M.; Quartuccio, Luca; Sacco, S.; De Marchi, G.; Pozzato, G.; Mazzaro, C.; Ferraccioli, G.; Migone, T.; DE VITA, Salvatore
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
2008-01-01 Baldini, C; DE RE, V; DE VITA, Salvatore; Fabris, M; Ferri, C; Mazzaro, C; Pozzato, G; Quartuccio, Luca; Salvin, S.
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes
2008-01-01 Fabris, M; Quartuccio, Luca; De Re, V; Pozzato, G; Mazzaro, C; Tavoni, A; Ferri, C; Salvin, S; Lerussi, A; Fabro, C; Bombardieri, S; DE VITA, Salvatore
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?
2008-01-01 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren's Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma
2008-01-01 Quartuccio, Luca; Fabris, M; Moretti, M; Barone, F; Bombardieri, M; Rupolo, M; Lombardi, S; Pitzalis, C; Beltrami, Ca; Curcio, Francesco; DE VITA, Salvatore
Long-Term Effects of Rituximab in Rheumatoid Arthritis Clinical, Biologic, and Pharmacogenetic Aspects
2009-01-01 Quartuccio, Luca; Lombardi, S; Fabris, M; Masolini, P; Saracco, M; Pellerito, R; DE VITA, Salvatore
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis
2009-01-01 Quartuccio, Luca; Salvin, S; Saracco, M; Lombardi, S; Fabris, M; Mansutti, E; Maset, M; Pellerito, S; DE VITA, Salvatore
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease
2009-01-01 Fabris, M.; De Vita, S.; Visentini, D.; Fabro, C.; Picierno, A.; Lerussi, A.; Villalta, D.; Alessio, M. G.; Tampoia, M.; Tonutti, E.
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
2009-01-01 Atzeni, F; Benucci, M; Cimmino, M; Cutolo, M; DE VITA, Salvatore; Fabris, Martina; Masolini, Paola; Morassi, P; Pellerito, R; Quartuccio, Luca; Salvin, Sara; Saracco, M; SARZI PUTTINI, P.
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
2010-01-01 Fabris, M; Quartuccio, Luca; Lombardi, S; Benucci, M; Manfredi, M; Saracco, M; Atzeni, F; Morassi, P; Cimmino, Ma; Pontarini, E; Fabro, C; Pellerito, R; Sarzi Puttini, P; Cutolo, M; Carletto, A; Bambara, Lm; Fischetti, F; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore
BLyS and April serum levels in patients with autoimmune thyroid diseases.
2010-01-01 Fabris, M; Grimaldi, F; Villalta, D; Picierno, A; Fabro, C; Bolzan, M; DE VITA, Salvatore; Tonutti, E.
Serum levels of anti-CPP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab
2010-01-01 Fabris, Martina; DE VITA, Salvatore; Blasone, Nadia; Visentini, Daniela; Pezzarini, Elena; Pontarini, Elena; Fabro, Cinzia; Quartuccio, Luca; Mazzolini, Saulle; Curcio, Francesco; Tonutti, Elio
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases
2011-01-01 Fabris, M; Tonutti, E; Panighel, C; Blasone, N; Visentini, D; Pizzolitto, S; De Maglio, G; Isola, Miriam; Curcio, Francesco; Grimaldi, F.
Chlamydophila psittaci subclinical infection in chronic polyarthritis
2011-01-01 Fabris, M.; DE VITA, Salvatore; Pasini, E.; Quartuccio, Luca; Pontarini, E.; Lombardi, S.; Fabro, C.; Sarzi Puttini, P.; Pellerito, R.; Belucci, M.; Morassi, P.; Biasi, D.; Curcio, Francesco; Dolcetti, R.
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study.
2012-01-01 DE VITA, Salvatore; le Seror, R; Quartuccio, Luca; Desmoulins, F; Salvin, S; Baron, G; Fabris, Martina; Ravaud, P; Isola, Miriam; Mariette, X.
Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism
2012-01-01 Quartuccio, Luca; Salvin, S; Fabris, M; Benucci, M; Pellerito, R; Furian, C; Masolini, P; Cimmino, M; Troncon, M. G.; Guarrera, G. M.; DE VITA, Salvatore
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
2012-01-01 DE VITA, Salvatore; Quartuccio, Luca; S., Salvin; L., Corazza; A., Zabotti; M., Fabris
Role e of oral cyclophosphamide in the treatment of giant cell arteritis
2012-01-01 Quartuccio, L; Maset, M; De Maglio, G; Pontarini, E; Fabris, M; Mansutti, E.; Mariuzzi, L; Pizzolitto, S; Beltrami, Ca; De Vita, S
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis
2012-01-01 Fabris, M; Quartuccio, Luca; Lombardi, S; Saracco, M; Atzeni, F; Carletto, A; Cimmino, M; Fabro, C; Pontarini, E; Pellerito, R; Bambara, Lm; SARZI PUTTINI, P; Cutolo, M; Manfredi, M; Benucci, M; Morassi, P; Fischetti, F; Padovan, M; Govoni, M; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link?
2012-01-01 Stinco, Giuseppe; Fabris, M; Pasini, E; Pontarini, E; Patriarca, Mm; Piccirillo, F; DE VITA, Salvatore; Dolcetti, R.
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.
2013-01-01 Tobón, Gj; Saraux, A; Gottenberg, Je; Quartuccio, Luca; Fabris, M; Seror, R; Devauchelle Pensec, V; Morel, J; Rist, S; Mariette, X; DE VITA, Salvatore; Youinou, P; Pers, J. O.
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study.
2013-01-01 Mariette, X; Seror, R; Quartuccio, Luca; Baron, G; Salvin, S; Fabris, M; Desmoulins, F; Nocturne, G; Ravaud, P; DE VITA, Salvatore
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands
2013-01-01 Quartuccio, Luca; Salvin, S.; Fabris, M.; Maset, M.; Pontarini, E.; Isola, Miriam; DE VITA, Salvatore
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers.
2013-01-01 Fabris, M; Quartuccio, Luca; Vital, E; Pontarini, E; Salvin, S; Fabro, C; Zabotti, A; Benucci, M; Manfredi, M; Ravagnani, V; Biasi, D; Atzeni, F; Sarzi Puttini, P; Morassi, P; Fischetti, F; Bazzicchi, L; Saracco, M; Pellerito, R; Cimmino, M; Carraro, V; Semeraro, A; Schiavon, F; Caporali, R; Bortolotti, R; Govoni, M; Fogolari, Federico; Tonutti, E; Bombardieri, S; Emery, P; DE VITA, Salvatore
Anti-phosphatidylserine/prothrombin Autoantibodies Significantly Improve The Laboratory Diagnostic Process Of Anti-phospholipids Antibody Syndrome.
2014-01-01 Cifu, A; Zago, S; Poz, A; Giacomello, R; Tonutti, E; Curcio, F; Fabris, M
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.
2014-01-01 Quartuccio, Luca; Fabris, M; Pontarini, E; Salvin, S; Zabotti, A; Benucci, M; Manfredi, M; Biasi, D; Ravagnani, V; Atzeni, F; Sarzi Puttini, P; Morassi, P; Fischetti, F; Tomietto, P; Bazzichi, L; Saracco, M; Pellerito, R; Cimmino, M; Schiavon, F; Carraro, V; Semeraro, A; Caporali, R; Cavagna, L; Bortolotti, R; Paolazzi, G; Govoni, M; Bombardieri, S; DE VITA, Salvatore
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
2014-01-01 DE VITA, Salvatore; Quartuccio, Luca; Salvin, S; Picco, L; Scott, Cathryn Anne; Rupolo, M; Fabris, M.
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
2014-01-01 Fabris, M; Dolcetti, R; Pasini, E; Quartuccio, Luca; Pontarini, E; Salvin, S; Ponzoni, M; Scott, Cathryn Anne; DE VITA, Salvatore
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
2014-01-01 M., Fabris; Giacomello, Roberta; A., Poz; L., Pantarotto; N., Tanzi; Curcio, Francesco; E., Tonutti
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease.
2015-01-01 Naviglio, S; Stocco, G; Cuzzoni, E; Favretto, D; De Iudicibus, S; Lucafo, M; Fabris, M; Cifu, A; Martelossi, Simone; Taddio, A; Ventura, A; Decorti, G
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients
2015-01-01 Fabris, Martina; Zago, Silvia; Liguori, Marco; Trevisan, Maria Teresa; Zanatta, Manuela; Comici, Alberto; Zanette, Giorgio; Carlin, Eva; Curcio, Francesco; Tonutti, Elio
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study
2015-01-01 DE VITA, Salvatore; Quartuccio, Luca; Seror, Raphaèle; Salvin, Sara; Ravaud, Philippe; Fabris, Martina; Nocturne, Gaétane; Gandolfo, Saviana; Isola, Miriam; Mariette, Xavier
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared
2015-01-01 Fabris, Martina; Pistis, Cinzia; Zabotti, Alen; Picco, Luca; Curcio, Francesco; Tonutti, Elio; DE VITA, Salvatore
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome
2015-01-01 Pontarini, Elena; Fabris, Martina; Quartuccio, Luca; Cappeletti, Monica; Calcaterra, Francesca; Roberto, Alessandra; Curcio, Francesco; Mavilio, Domenico; Della Bella, Silvia; DE VITA, Salvatore
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities .
2016-01-01 Fabris, M; Cifu, A; Pistis, C; Giacomello, R; Siegaducaton, M; Tonutti, E; Curcio, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) | 1-gen-2001 | DE VITA, Salvatore; De Marchi, G; Sacco, S; Gremese, E; Fabris, M; Ferraccioli, G. F. | |
| TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results | 1-gen-2002 | Fabris, Martina; Di Poi, E.; Sacco, S.; Damante, Giuseppe; Sinigaglia, L.; Ferraccioli, Gianfranco | |
| Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. | 1-gen-2002 | Damante, Giuseppe; D'Elia, Angela Valentina; Di, Pe; Fabris, Martina; Ferraccioli, Gianfranco; Sinigaglia, L. | |
| B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis | 1-gen-2004 | Quartuccio, Luca; Fabris, M; Ferraccioli, G. | |
| SYSTEMIC CONNECTIVE TISSUE DISEASE COMPLICATED BY CASTLEMAN'S DISEASE: REPORT OF A CASE AND REVIEW OF THE LITERATURE | 1-gen-2004 | DE MARCHI, G; DE VITA, Salvatore; Fabris, M; Scott, Cathryn Anne; Ferraccioli, G. | |
| -238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS | 1-gen-2005 | Tolusso, B; Fabris, M; Caporali, R; Cuomo, G; Isola, Miriam; Soldano, F; Montecucco, C; Valentini, G; Ferraccioli, G. | |
| Type II mixed cryglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses | 1-gen-2006 | Boiocchi, M; Carbone, A; Damacco, F; DE RE, V; DE VITA, Salvatore; Fabris, Martina; Gasparotto, D; Gloghini, A; Marzotto, A; Sansonno, D; Simula, M. P.; Tucci, F. A. | |
| Rituximab treatment for Glomerulonephritis in HCV-associated Mixed Cryoglobulinemia: efficacy and safety in the lack of steroids | 1-gen-2006 | Quartuccio, Luca; Soardo, G; Romano, Giulio; Zaja, F; Scott, Cathryn Anne; DE MARCHI, G; Fabris, M; Ferraccioli, G; DE VITA, Salvatore | |
| HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations | 1-gen-2006 | De Re, V.; Sansonno, D.; Simula, M. P.; Caggiari, L.; Gasparotto, D; Fabris, M.; Tucci, F. A.; Racanelli, V.; Talamini, R; Campagnolo, M.; Geremia, S.; Dammacco, F.; De Vita, S. | |
| Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. | 1-gen-2006 | Quartuccio, Luca; De Re, V.; Fabris, M; Marzotto, A.; Franzolini, N; Gasparotto, D.; Caggiari, L.; Ferraccioli, G.; Scott, Cathryn Anne; DE VITA, Salvatore | |
| Twist is substrate for caspase cleavage and proteasome-mediated degradation | 1-gen-2006 | Demontis, S; Rigo, C; Piccinin, S; Mizzau, Michela; Sonego, Maura; Fabris, Martina; Brancolini, Claudio; Maestro, R. | |
| Rituximab in mixed cryoglobulinemia: increased experience and perspectives | 1-gen-2007 | DE VITA, Salvatore; Quartuccio, Luca; Fabris, M. | |
| Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: Association with nephritis RID A-8026-2008 | 1-gen-2007 | Quartuccio, Luca; Fabris, M; Salvin, S; Isola, Miriam; Soldano, F; Falleti, E; Beltrami, Ca; De Re, V; DE VITA, Salvatore | |
| Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. | 1-gen-2007 | Quartuccio, Luca; De Marchi, G.; Fabris, M.; DE VITA, Salvatore | |
| Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease | 1-gen-2007 | Fabris, M; Visentini, D; De Re, V; Picierno, A; Maieron, R; Cannizzaro, R; Villalta, D; Curcio, Francesco; DE VITA, Salvatore; Tonutti, E. | |
| B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection | 1-gen-2007 | Fabris, M.; Quartuccio, Luca; Sacco, S.; De Marchi, G.; Pozzato, G.; Mazzaro, C.; Ferraccioli, G.; Migone, T.; DE VITA, Salvatore | |
| Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. | 1-gen-2008 | Baldini, C; DE RE, V; DE VITA, Salvatore; Fabris, M; Ferri, C; Mazzaro, C; Pozzato, G; Quartuccio, Luca; Salvin, S. | |
| Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes | 1-gen-2008 | Fabris, M; Quartuccio, Luca; De Re, V; Pozzato, G; Mazzaro, C; Tavoni, A; Ferri, C; Salvin, S; Lerussi, A; Fabro, C; Bombardieri, S; DE VITA, Salvatore | |
| Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? | 1-gen-2008 | DE VITA, Salvatore; Quartuccio, Luca; Fabris, M. | |
| Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren's Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma | 1-gen-2008 | Quartuccio, Luca; Fabris, M; Moretti, M; Barone, F; Bombardieri, M; Rupolo, M; Lombardi, S; Pitzalis, C; Beltrami, Ca; Curcio, Francesco; DE VITA, Salvatore | |
| Long-Term Effects of Rituximab in Rheumatoid Arthritis Clinical, Biologic, and Pharmacogenetic Aspects | 1-gen-2009 | Quartuccio, Luca; Lombardi, S; Fabris, M; Masolini, P; Saracco, M; Pellerito, R; DE VITA, Salvatore | |
| Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis | 1-gen-2009 | Quartuccio, Luca; Salvin, S; Saracco, M; Lombardi, S; Fabris, M; Mansutti, E; Maset, M; Pellerito, S; DE VITA, Salvatore | |
| B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease | 1-gen-2009 | Fabris, M.; De Vita, S.; Visentini, D.; Fabro, C.; Picierno, A.; Lerussi, A.; Villalta, D.; Alessio, M. G.; Tampoia, M.; Tonutti, E. | |
| Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis | 1-gen-2009 | Atzeni, F; Benucci, M; Cimmino, M; Cutolo, M; DE VITA, Salvatore; Fabris, Martina; Masolini, Paola; Morassi, P; Pellerito, R; Quartuccio, Luca; Salvin, Sara; Saracco, M; SARZI PUTTINI, P. | |
| Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis | 1-gen-2010 | Fabris, M; Quartuccio, Luca; Lombardi, S; Benucci, M; Manfredi, M; Saracco, M; Atzeni, F; Morassi, P; Cimmino, Ma; Pontarini, E; Fabro, C; Pellerito, R; Sarzi Puttini, P; Cutolo, M; Carletto, A; Bambara, Lm; Fischetti, F; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore | |
| BLyS and April serum levels in patients with autoimmune thyroid diseases. | 1-gen-2010 | Fabris, M; Grimaldi, F; Villalta, D; Picierno, A; Fabro, C; Bolzan, M; DE VITA, Salvatore; Tonutti, E. | |
| Serum levels of anti-CPP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab | 1-gen-2010 | Fabris, Martina; DE VITA, Salvatore; Blasone, Nadia; Visentini, Daniela; Pezzarini, Elena; Pontarini, Elena; Fabro, Cinzia; Quartuccio, Luca; Mazzolini, Saulle; Curcio, Francesco; Tonutti, Elio | |
| The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases | 1-gen-2011 | Fabris, M; Tonutti, E; Panighel, C; Blasone, N; Visentini, D; Pizzolitto, S; De Maglio, G; Isola, Miriam; Curcio, Francesco; Grimaldi, F. | |
| Chlamydophila psittaci subclinical infection in chronic polyarthritis | 1-gen-2011 | Fabris, M.; DE VITA, Salvatore; Pasini, E.; Quartuccio, Luca; Pontarini, E.; Lombardi, S.; Fabro, C.; Sarzi Puttini, P.; Pellerito, R.; Belucci, M.; Morassi, P.; Biasi, D.; Curcio, Francesco; Dolcetti, R. | |
| Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. | 1-gen-2012 | DE VITA, Salvatore; le Seror, R; Quartuccio, Luca; Desmoulins, F; Salvin, S; Baron, G; Fabris, Martina; Ravaud, P; Isola, Miriam; Mariette, X. | |
| Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism | 1-gen-2012 | Quartuccio, Luca; Salvin, S; Fabris, M; Benucci, M; Pellerito, R; Furian, C; Masolini, P; Cimmino, M; Troncon, M. G.; Guarrera, G. M.; DE VITA, Salvatore | |
| Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. | 1-gen-2012 | DE VITA, Salvatore; Quartuccio, Luca; S., Salvin; L., Corazza; A., Zabotti; M., Fabris | |
| Role e of oral cyclophosphamide in the treatment of giant cell arteritis | 1-gen-2012 | Quartuccio, L; Maset, M; De Maglio, G; Pontarini, E; Fabris, M; Mansutti, E.; Mariuzzi, L; Pizzolitto, S; Beltrami, Ca; De Vita, S | |
| The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis | 1-gen-2012 | Fabris, M; Quartuccio, Luca; Lombardi, S; Saracco, M; Atzeni, F; Carletto, A; Cimmino, M; Fabro, C; Pontarini, E; Pellerito, R; Bambara, Lm; SARZI PUTTINI, P; Cutolo, M; Manfredi, M; Benucci, M; Morassi, P; Fischetti, F; Padovan, M; Govoni, M; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore | |
| Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? | 1-gen-2012 | Stinco, Giuseppe; Fabris, M; Pasini, E; Pontarini, E; Patriarca, Mm; Piccirillo, F; DE VITA, Salvatore; Dolcetti, R. | |
| Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. | 1-gen-2013 | Tobón, Gj; Saraux, A; Gottenberg, Je; Quartuccio, Luca; Fabris, M; Seror, R; Devauchelle Pensec, V; Morel, J; Rist, S; Mariette, X; DE VITA, Salvatore; Youinou, P; Pers, J. O. | |
| Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. | 1-gen-2013 | Mariette, X; Seror, R; Quartuccio, Luca; Baron, G; Salvin, S; Fabris, M; Desmoulins, F; Nocturne, G; Ravaud, P; DE VITA, Salvatore | |
| BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands | 1-gen-2013 | Quartuccio, Luca; Salvin, S.; Fabris, M.; Maset, M.; Pontarini, E.; Isola, Miriam; DE VITA, Salvatore | |
| The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. | 1-gen-2013 | Fabris, M; Quartuccio, Luca; Vital, E; Pontarini, E; Salvin, S; Fabro, C; Zabotti, A; Benucci, M; Manfredi, M; Ravagnani, V; Biasi, D; Atzeni, F; Sarzi Puttini, P; Morassi, P; Fischetti, F; Bazzicchi, L; Saracco, M; Pellerito, R; Cimmino, M; Carraro, V; Semeraro, A; Schiavon, F; Caporali, R; Bortolotti, R; Govoni, M; Fogolari, Federico; Tonutti, E; Bombardieri, S; Emery, P; DE VITA, Salvatore | |
| Anti-phosphatidylserine/prothrombin Autoantibodies Significantly Improve The Laboratory Diagnostic Process Of Anti-phospholipids Antibody Syndrome. | 1-gen-2014 | Cifu, A; Zago, S; Poz, A; Giacomello, R; Tonutti, E; Curcio, F; Fabris, M | |
| The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. | 1-gen-2014 | Quartuccio, Luca; Fabris, M; Pontarini, E; Salvin, S; Zabotti, A; Benucci, M; Manfredi, M; Biasi, D; Ravagnani, V; Atzeni, F; Sarzi Puttini, P; Morassi, P; Fischetti, F; Tomietto, P; Bazzichi, L; Saracco, M; Pellerito, R; Cimmino, M; Schiavon, F; Carraro, V; Semeraro, A; Caporali, R; Cavagna, L; Bortolotti, R; Paolazzi, G; Govoni, M; Bombardieri, S; DE VITA, Salvatore | |
| Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. | 1-gen-2014 | DE VITA, Salvatore; Quartuccio, Luca; Salvin, S; Picco, L; Scott, Cathryn Anne; Rupolo, M; Fabris, M. | |
| High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. | 1-gen-2014 | Fabris, M; Dolcetti, R; Pasini, E; Quartuccio, Luca; Pontarini, E; Salvin, S; Ponzoni, M; Scott, Cathryn Anne; DE VITA, Salvatore | |
| The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation | 1-gen-2014 | M., Fabris; Giacomello, Roberta; A., Poz; L., Pantarotto; N., Tanzi; Curcio, Francesco; E., Tonutti | |
| Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. | 1-gen-2015 | Naviglio, S; Stocco, G; Cuzzoni, E; Favretto, D; De Iudicibus, S; Lucafo, M; Fabris, M; Cifu, A; Martelossi, Simone; Taddio, A; Ventura, A; Decorti, G | |
| Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients | 1-gen-2015 | Fabris, Martina; Zago, Silvia; Liguori, Marco; Trevisan, Maria Teresa; Zanatta, Manuela; Comici, Alberto; Zanette, Giorgio; Carlin, Eva; Curcio, Francesco; Tonutti, Elio | |
| Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study | 1-gen-2015 | DE VITA, Salvatore; Quartuccio, Luca; Seror, Raphaèle; Salvin, Sara; Ravaud, Philippe; Fabris, Martina; Nocturne, Gaétane; Gandolfo, Saviana; Isola, Miriam; Mariette, Xavier | |
| The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared | 1-gen-2015 | Fabris, Martina; Pistis, Cinzia; Zabotti, Alen; Picco, Luca; Curcio, Francesco; Tonutti, Elio; DE VITA, Salvatore | |
| Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome | 1-gen-2015 | Pontarini, Elena; Fabris, Martina; Quartuccio, Luca; Cappeletti, Monica; Calcaterra, Francesca; Roberto, Alessandra; Curcio, Francesco; Mavilio, Domenico; Della Bella, Silvia; DE VITA, Salvatore | |
| Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . | 1-gen-2016 | Fabris, M; Cifu, A; Pistis, C; Giacomello, R; Siegaducaton, M; Tonutti, E; Curcio, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile